Results 141 to 150 of about 2,212,418 (287)

Educational role of nurses in joining the treatment of Systemic Arterial Hypertension: integrative literature review

O Mundo da Saúde, 2014
High blood pressure (HBP) is characterized as a chronic disease with a high prevalence of deaths worldwide. The study aims to describe the educational role of the nurse in compliance to treatment of systemic arterial hypertension.
Yasmin Fernandes Costa, Ocione Cristina de Araújo, Lucas Bruno Matias de Almeida, Selma Maria da Fonseca Viegas   +3 more
doaj  

The relationship between morning blood pressure surge and asymptomatic episodes of paroxysmal atrial fibrillation in patients with systemic arterial hypertension. [PDF]

Turk J Med Sci, 2022
Taş Ü, Taş S, Yavuz İ.
europepmc   +1 more source

Possible therapeutic repositioning of valproic acid: From epileptic seizures to acute kidney injury

British Journal of Clinical Pharmacology, EarlyView.
Valproic acid, an anticonvulsant, may be repositioned to prevent acute kidney injury due to ischemia followed by reperfusion. It preserves renal functions, electrolyte homeostasis and active sodium transport in kidney tubules, and blocks the onset of hypertension.
Danilo Alves‐Bezerra, Luiza B. Negreiros, Amaury Pereira‐Acácio, Isadora G. Almeida, João P. M. Veloso‐Santos, Jarlene A. Lopes, Glória Costa‐Sarmento, Humberto Muzi‐Filho, Adalberto Vieyra   +8 more
wiley   +1 more source

Plasma Levels of Matrix Metalloproteinases 2 and 9 in Patients with Chronic Chagas Heart Disease and Systemic Arterial Hypertension: Correlation with TGF-Beta Plasma Levels. [PDF]

Cardiol Res Pract, 2023
Bestetti RB, Dellalibera-Joviliano R, Rizzi E, Bonacio GF, Faria-Jr M, Furlan-Daniel R, Castro-França S.   +6 more
europepmc   +1 more source

Hypertension in obesity: A focus on individualized pharmacotherapy and the role of body composition, on behalf of the European Society of Hypertension Working Group on Diabetes and Metabolic Risk Factors and Working Group on Lifestyle, Cardiovascular Pharmacotherapy and Adherence

British Journal of Clinical Pharmacology, EarlyView.
Hypertension in obesity represents a major global health challenge, closely linked to the global epidemics of obesity, type 2 diabetes and metabolic dysfunction. Excess adiposity contributes to elevated blood pressure through multiple, interrelated mechanisms, including activation of the renin–angiotensin–aldosterone system, sympathetic nervous system ...
Christina Antza, Andrej Belancic, Jens Jordan, Alberto Esteban, Anna Oliveras, Ryan McNally, Panagiota Anyfanti, Jorie Versmissen, María S. Fernández‐Alfonso, Vasilios Kotsis, Thomas Weber, Alexandre Persu, Reinhold Kreutz   +12 more
wiley   +1 more source

Family with systemic arterial hypertension: epidemiological profile. [PDF]

Rev Peru Med Exp Salud Publica, 2022
Villarreal Ríos E, Huato Solorio A, Galicia Rodríguez L, Escorcia Reyes V, Vargas Daza ER, Carballo Santander E.   +5 more
europepmc   +1 more source

Therapeutic Challenges And Advances In The Management Of Systemic Sclerosis-Related Pulmonary Arterial Hypertension (SSc-PAH)

, 2019
Rahul G Argula,1 Celine Ward,2 Carol Feghali-Bostwick2 1Department of Medicine, Division of Pulmonary and Critical Care Medicine, Medical University of South Carolina, Charleston, SC 29425, USA; 2Department of Medicine, Division of Rheumatology, Medical ...
Feghali-Bostwick C, Argula RG, Ward C
core  

Comparing outcomes using low‐dose apixaban and anti‐Xa monitoring and vitamin K antagonists in patients with renal replacement therapy

British Journal of Clinical Pharmacology, EarlyView.
Background Guidelines recommend oral anticoagulation for stroke prevention in atrial fibrillation and secondary prevention of venous thromboembolism. Outside the United States, apixaban is unlicensed for use in patients with end‐stage renal disease (ESRD) receiving renal replacement therapy (RRT).
John K. Bartoli‐Abdou, Alexander T. Cohen, Lucy Vernon, Victoria Collings, Ubonphan Chaichana, Natasha Moore, Hamda Jibril, Li Wei, Nicola Kumar, Karen A. Breen, Andrew J. Doyle   +10 more
wiley   +1 more source

Bioactive Natural Products against Systemic Arterial Hypertension: A Past 20-Year Systematic and Prospective Review. [PDF]

Evid Based Complement Alternat Med, 2022
da Silva MG, Barbosa SLF, Silva DS, Silva DS, Bezerra IBM, Alves Bezerra É, Coelho AG, Pinheiro da Silva Morais IC, Rezende-Júnior LM, do Carmo IS, Lima-Neto JS, Comerma-Steffensen SG, Citó AMDGL, Arcanjo DDR.   +13 more
europepmc   +1 more source

The Swiss registry for pulmonary arterial hypertension: the paediatric experience.

, 2007
Pulmonary arterial hypertension is a rare disease with a poor prognosis. Epidemiological data are scarce, particularly in the paediatric population. A registry was recently developed in order to collect epidemiological data on patients with pulmonary ...
Tolsa, J.F., Fasnacht, M.S., Beghetti, M.   +2 more
core